PDI Congress stands for Parenteral Drug Industry Congress. Started in 2008, PDI Congress focuses on parenteral drug industry, aiming to establish a platform for regulatory authorities and pharmaceutical industry, enhance communication and technical exchange between
local and overseas companies, promote further development of Chinese pharmaceutical industry. Every year, more than
700 attendees participate PDI congress, sharing expertise and communicating among variety forums,
covering Regulatory & Policy, Industrial trends, Research & Development, Manufacturing Quality,
Packaging and Excipients, Injection Safety, Supply Chain Security, Investment and etc.